Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 11837839)

Published in J Bone Joint Surg Br on January 01, 2002

Authors

G Bacci1, S Ferrari, S Lari, M Mercuri, D Donati, A Longhi, C Forni, F Bertoni, M Versari, E Pignotti

Author Affiliations

1: Department of Chemotherapy, Rizzoli Orthopaedic Institute, Bologna, Italy.

Articles citing this

Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis (2007) 2.53

Size matters for sarcomas! Ann R Coll Surg Engl (2006) 1.48

Proximal and total humerus reconstruction with the use of an aortograft mesh. Clin Orthop Relat Res (2010) 1.19

Functional outcome in patients with osteosarcoma around the knee joint treated by minimised surgery. Int Orthop (2007) 1.06

Analysis of limb function after various reconstruction methods according to tumor location following resection of pediatric malignant bone tumors. World J Surg Oncol (2010) 1.02

Does increased rate of limb-sparing surgery affect survival in osteosarcoma? Clin Orthop Relat Res (2010) 0.99

Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma. Clin Orthop Relat Res (2011) 0.98

Pathological fractures in children. Bone Joint Res (2012) 0.93

Classification, imaging, biopsy and staging of osteosarcoma. Indian J Orthop (2014) 0.93

Comparison of the outcome of conventional osteosarcoma at two specialist international orthopaedic oncology centres. Sarcoma (2004) 0.92

The clinical value of combined use of MR imaging and multi-slice spiral CT in limb salvage surgery for orthopaedic oncology patients: initial experience in nine patients. Radiol Oncol (2012) 0.87

Role of surgical margin on local recurrence in high risk extremity osteosarcoma: a case-controlled study. Clin Orthop Surg (2013) 0.85

Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient. Sarcoma (2015) 0.84

Review of Osteosarcoma and Current Management. Rheumatol Ther (2016) 0.81

Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma. Pediatr Blood Cancer (2014) 0.81

Can bone tissue engineering contribute to therapy concepts after resection of musculoskeletal sarcoma? Sarcoma (2013) 0.81

The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev (2013) 0.79

A comparative study between limb-salvage and amputation for treating osteosarcoma. J Bone Oncol (2016) 0.78

Surgical technique: Tibia cortical strut autograft interposition arthrodesis after distal radius resection. Clin Orthop Relat Res (2013) 0.77

High tumor volume and local recurrence following surgery in osteosarcoma: A retrospective study. Indian J Orthop (2014) 0.76

Distraction osteogenesis and arthrodesis as a new surgical option for chondrosarcoma in the distal tibia. World J Surg Oncol (2015) 0.75

Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience. Front Oncol (2016) 0.75

Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma. Sci Rep (2016) 0.75

Limb salvage surgery in bone tumors: a retrospective study of 50 cases in a single center. Indian J Surg Oncol (2013) 0.75

The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro. Onco Targets Ther (2016) 0.75

A case report of apatinib in treating osteosarcoma with pulmonary metastases. Medicine (Baltimore) (2017) 0.75

A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology. Oncotarget (2017) 0.75

Articles by these authors

The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet (1999) 4.77

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med (1995) 4.11

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA (1996) 4.03

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res (2000) 3.02

Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol (1997) 2.87

Synovial sarcoma: identification of low and high risk groups. Cancer (1999) 2.82

ISWI is an ATP-dependent nucleosome remodeling factor. Mol Cell (1999) 2.68

Does lead overload develop in hemodialysis patients? Nephron (1989) 2.52

Campylobacter pylori in abattoir workers: is it a zoonosis? Lancet (1988) 2.41

Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 2.41

Aneurysmal bone cyst of the mobile spine: report on 41 cases. Spine (Phila Pa 1976) (2001) 2.37

Coding sequence and growth regulation of the human vimentin gene. Mol Cell Biol (1986) 2.34

The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J (1992) 2.18

Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr (2002) 2.12

Cloning of the mitogen-activated S6 kinase from rat liver reveals an enzyme of the second messenger subfamily. Proc Natl Acad Sci U S A (1990) 2.09

Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol (2000) 2.06

Cancer genetics clinics: target population and consultees' expectations. Eur J Cancer (1996) 1.88

Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem (1998) 1.86

Acf1, the largest subunit of CHRAC, regulates ISWI-induced nucleosome remodelling. EMBO J (2001) 1.81

Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80

Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin. J Clin Oncol (1998) 1.80

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol (2000) 1.77

Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71

Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest (1997) 1.70

Long-term results of spine surgery in Duchenne muscular dystrophy. Neuromuscul Disord (1996) 1.61

Giant cell tumor of the bones of the hand and foot. Cancer (2000) 1.61

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer (1993) 1.58

Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol (1997) 1.56

En bloc resections of bone tumors of the thoracolumbar spine. A preliminary report on 29 patients. Spine (Phila Pa 1976) (1996) 1.50

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol (2003) 1.50

Clinical significance of bcl-2 (MBR)/JH rearrangement in the peripheral blood of patients with diffuse large B-cell lymphomas. Ann Oncol (1996) 1.50

Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol (1991) 1.49

Mesenchymal chondrosarcoma of bone and soft tissues. Cancer (1983) 1.48

The gastric marginal zone B-cell lymphoma of MALT type. Blood (2000) 1.47

Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytic changes and fluid cavities at imaging. Skeletal Radiol (2009) 1.47

Selenium status, fatty acids, vitamins A and E, and aging: the Nove Study. Am J Clin Nutr (1994) 1.46

Preoperative therapy versus immediate surgery in nonmetastatic osteosarcoma. J Clin Oncol (2003) 1.46

Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am (1981) 1.46

Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli. J Clin Oncol (2000) 1.45

Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma (1997) 1.44

[ General postural rehabilitation in musculoskeletal diseases: scientific evidence and clinical indications]. Reumatismo (2007) 1.44

Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol (2009) 1.44

Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution. Int Orthop (2006) 1.43

Fibrocartilagenous mesenchymoma of bone. Am J Surg Pathol (1993) 1.42

Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Ann Oncol (2003) 1.42

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. Ann Oncol (2011) 1.40

Absolute alcohol in esophageal vein sclerosis. Gastrointest Endosc (1988) 1.40

A recently developed bifacial platelet-rich fibrin matrix. Eur Cell Mater (2010) 1.40

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.39

The human carotid atherosclerotic plaque stimulates angiogenesis on the chick chorioallantoic membrane. Atherosclerosis (1992) 1.39

Construction and in vitro functional evaluation of a low-density lipoprotein receptor/transferrin fusion protein as a therapeutic tool for familial hypercholesterolemia. Hum Gene Ther (1999) 1.39

Microsatellite instability in gastric MALT lymphomas and other associated neoplasms. Ann Oncol (1999) 1.38

Gene expression profiling in MDS and AML: potential and future avenues. Leukemia (2011) 1.38

Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research. J Clin Oncol (1989) 1.37

Hmg4, a new member of the Hmg1/2 gene family. Genomics (1998) 1.37

Identification of 40 S ribosomal protein S6 phosphorylation sites in Swiss mouse 3T3 fibroblasts stimulated with serum. J Biol Chem (1993) 1.36

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma. Ann Oncol (2011) 1.36

Structural and functional analysis of a growth-regulated gene, the human calcyclin. J Biol Chem (1987) 1.36

Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer (2001) 1.34

Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet (2004) 1.33

Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. J Med Virol (1993) 1.32

Template-imprinted nanostructured surfaces for protein recognition. Nature (1999) 1.32